RAINBOW

Rainbow Childrens Medicare Financial Results

₹1,250.20+0.85%
Market cap
₹12,682 crore
P/E
44.4
P/B
7.70
ROE
17.9%
Dividend yield
0.28%

For the year ended Mar 2022, Rainbow Childrens Medicare reported revenue of ₹974 crore and net profit of ₹139 crore, against ₹1,161 crore and ₹212 crore a year earlier.

Rainbow Childrens Medicare annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Rainbow Childrens Medicare annual profit and loss (₹ crore)
ItemMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue9741,1611,2861,4951,6781,820
Expenses6697568501,0011,1291,245
Operating profit305405436494548575
Operating margin %31%35%34%33%33%32%
Other income192230463835
Interest535559727881
Depreciation8390112138151159
Profit before tax187282295330358371
Tax %26%25%26%26%21%22%
Net profit139212218244282290
EPS (₹)13.6220.7721.3823.9727.4428.13
Dividend payout %——————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Rainbow Childrens Medicare financial results — frequently asked questions

What is Rainbow Childrens Medicare's annual revenue and net profit?

For the financial year ended Mar 2022, Rainbow Childrens Medicare's revenue was ₹974 crore and net profit ₹139 crore; net profit fell 34.43% from ₹212 crore in Mar 2023.

How fast has Rainbow Childrens Medicare grown over three years?

From Mar 2025 to Mar 2022, Rainbow Childrens Medicare's revenue grew at a compound annual rate of -13.3% and net profit at -17.1%. Past growth does not indicate future results.

What is the EPS of Rainbow Childrens Medicare?

Annual EPS for Mar 2022 was ₹13.62.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Rainbow Childrens Medicare With ATS

Track RAINBOW live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.